BIOMAT Database Logo BIOMAT Database Logo

Potent and selective inhibition of human immunodeficiency virus type 1 transcription by piperazinyloxoquinoline derivatives. 1997

M Baba, and M Okamoto, and M Makino, and Y Kimura, and T Ikeuchi, and T Sakaguchi, and T Okamoto
Center for Chronic Viral Diseases, Faculty of Medicine, Kagoshima University, Sakuragaoka, Japan. baba@med3.kufm.kagoshima-u.ac.jp

We have found novel piperazinyloxoquinoline derivatives to be potent and selective inhibitors of human immunodeficiency virus type 1 (HIV-1) replication in both acutely and chronically infected cells. 8-Difluoromethoxy-1-ethyl-6-fluoro-1,4-didehydro-7-[4-(2-met hoxyphenyl)-1-piperazinyl]-4-oxoquinoline-3-carboxylic acid (K-12), the most potent congener of the series, completely inhibited HIV-1 replication in acutely infected MOLT-4 cells at a concentration of 0.16 to 0.8 microM without showing any cytotoxicity. The compound completely suppressed tumor necrosis factor alpha (TNF-alpha)-induced HIV-1 expression in latently infected cells (OM-10.1) and constitutive viral production in chronically infected cells (MOLT-4/III(B)) at a concentration of 0.8 microM. K-12 could also inhibit HIV-1 antigen expression in OM-10.1 and MOLT-4/III(B) cells at this concentration. Northern blot analysis revealed that K-12 selectively prevented the accumulation of HIV-1 mRNA in MOLT-4/III(B) and TNF-alpha-treated OM-10.1 cells in a dose-dependent fashion. It was not inhibitory to HIV-1 Tat or the cellular transcription factors NF-kappaB and Sp1, suggesting that the piperazinyloxoquinoline derivatives are a group of HIV-1 transcription inhibitors with a unique mechanism of action.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011804 Quinolines
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

M Baba, and M Okamoto, and M Makino, and Y Kimura, and T Ikeuchi, and T Sakaguchi, and T Okamoto
Inhibition of human immunodeficiency virus type 1 transcription by N-aminoimidazole derivatives.
August 2007, Virology,
M Baba, and M Okamoto, and M Makino, and Y Kimura, and T Ikeuchi, and T Sakaguchi, and T Okamoto
Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
June 1991, Molecular pharmacology,
M Baba, and M Okamoto, and M Makino, and Y Kimura, and T Ikeuchi, and T Sakaguchi, and T Okamoto
Inhibition of human immunodeficiency virus type 1 transcription and replication by DNA sequence-selective plant lignans.
November 1995, Proceedings of the National Academy of Sciences of the United States of America,
M Baba, and M Okamoto, and M Makino, and Y Kimura, and T Ikeuchi, and T Sakaguchi, and T Okamoto
Inhibition of human immunodeficiency virus type 1 integration by diketo derivatives.
October 2002, Antimicrobial agents and chemotherapy,
M Baba, and M Okamoto, and M Makino, and Y Kimura, and T Ikeuchi, and T Sakaguchi, and T Okamoto
Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.
March 1993, Proceedings of the National Academy of Sciences of the United States of America,
M Baba, and M Okamoto, and M Makino, and Y Kimura, and T Ikeuchi, and T Sakaguchi, and T Okamoto
Thiadiazole derivatives: highly potent and selective inhibitors of human immunodeficiency virus type 1 (HIV-1) replications in vitro.
January 1997, Microbiology and immunology,
M Baba, and M Okamoto, and M Makino, and Y Kimura, and T Ikeuchi, and T Sakaguchi, and T Okamoto
Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference.
September 2002, Journal of virology,
M Baba, and M Okamoto, and M Makino, and Y Kimura, and T Ikeuchi, and T Sakaguchi, and T Okamoto
Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase.
March 1991, Proceedings of the National Academy of Sciences of the United States of America,
M Baba, and M Okamoto, and M Makino, and Y Kimura, and T Ikeuchi, and T Sakaguchi, and T Okamoto
Benzophenone derivatives: a novel series of potent and selective inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
May 1995, Journal of medicinal chemistry,
M Baba, and M Okamoto, and M Makino, and Y Kimura, and T Ikeuchi, and T Sakaguchi, and T Okamoto
Inhibition of cytopathic effect of human immunodeficiency virus type-1 by various phorbol derivatives.
April 2002, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!